作者：
April C,Watt [1]
;
Paloma,Cejas [2]
;
Molly J,DeCristo [3]
;
Otto,Metzger-Filho [4]
;
Enid Y N,Lam [5]
;
Xintao,Qiu [6]
;
Haley,BrinJones [7]
;
Nikolas,Kesten [1]
;
Rhiannon,Coulson [2]
;
Alba,Font-Tello [3]
;
Klothilda,Lim [6]
;
Raga,Vadhi [3]
;
Veerle W,Daniels [1]
;
Joan,Montero [2]
;
Len,Taing [3]
;
Clifford A,Meyer [3]
;
Omer,Gilan [3]
;
Charles C,Bell [7]
;
Keegan D,Korthauer [7]
;
Claudia,Giambartolomei [8]
;
Bogdan,Pasaniuc [3]
;
Ji-Heui,Seo [3]
;
Matthew L,Freedman [1]
;
Cynthia,Ma [2]
;
Matthew J,Ellis [1]
;
Ian,Krop [2]
;
Eric,Winer [9]
;
Anthony,Letai [10]
;
Myles,Brown [11]
;
Mark A,Dawson [12]
;
Henry W,Long [11]
;
Jean J,Zhao [3]
;
Shom,Goel [7]
作者单位：
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
[1]
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
[2]
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
[3]
Translational Oncology Laboratory, Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
[4]
CIBERONC CB16/12/00398, La Paz University Hospital, Madrid, Spain.
[5]
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
[6]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
[7]
Institute for Bioengineering of Catalonia, Barcelona, Spain.
[8]
Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
[9]
Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
[10]
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
[11]
Istituto Italiano di Tecnologia (IIT), Genoa, Italy.
[12]
Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
[13]
Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
[14]
Centre for Cancer Research, University of Melbourne, Parkville, Victoria, Australia.
[15]
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. Henry_Long@dfci.harvard.edu.
[16]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Henry_Long@dfci.harvard.edu.
[17]
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. Jean_Zhao@dfci.harvard.edu.
[18]
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. Jean_Zhao@dfci.harvard.edu.
[19]
The Broad Institute of MIT and Harvard, Cambridge, MA, USA. Jean_Zhao@dfci.harvard.edu.
[20]
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. shom.goel@petermac.org.
[21]
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia. shom.goel@petermac.org.
[22]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. shom.goel@petermac.org.
[23]
DOI
10.1038/s43018-020-00135-y
PMID
33997789
发布时间
2024-01-11
换一批
换一批
